---
{"dg-publish":true,"permalink":"/USMLE/Renal/Distal renal tubular acidosis (type 1)/"}
---

# Epidemiology


---
# Etiology
- Autoimmune diseases
- Chronic obstructive uropathy (e.g., congenital anomalies)
- Sickle cell nephropathy
- Drugs: ifosfamide, <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Infective disease/Antifungals\|amphotericin B]]</span>, lithium, <span style="background:rgba(240, 200, 0, 0.2)">[[USMLE/Pharmacology/Non-opioid analgesics\|NSAIDs]] (analgesic nephropathy)</span>

---
# Pathophysiology
The α-intercalated cells of the distal tubule are unable to secrete H<sup>+</sup> (apical) → ↓ intracellular production of HCO<sub>3</sub><sup>-</sup>  → ↓ HCO<sub>3</sub><sup>-</sup>/Cl<sup>-</sup> exchanger activity (basolateral) → decreased concentration of HCO<sub>3</sub><sup>-</sup> in the blood → metabolic acidosis

---
# Clinical features
- Nephrocalcinosis: calcium phosphate stones (due to an increase in urine pH
- Bone demineralization usually without overt rickets or osteomalacia (due to increased bone turnover)
- Impaired growth

---
# Diagnostics


---
# Treatment
<% tp.file.cursor() %>

---
